Up to 10 Years of Follow-Up Uphold Survival Benefit With Adjuvant Dabrafenib/Trametinib in Stage III Melanoma
The COMBI-AD dataset is the longest follow-up to date of adjuvant treatment for patients with stage III melanoma.
Source: onclive.com
Page 4 - Array Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Array Biopharma Today - Breaking & Trending Today
Pfizer Gets FDA OK of Drug Combination in Non-Small Cell Lung Cancer
By Colin Kellaher Pfizer has won expanded approval from the U.S. Food and Drug Administration of the combination of its Braftovi and Mektovi drugs for...
Source: marketwatch.com
FDA OKs Drug Combo in BRAF V600E-Mutated Metastatic NSCLC
The single-arm approval study reported an objective response rate of 75% among treatment-naive patients.
Source: medscape.com
Pfizer to cut R&D jobs in Boulder
Pfizer Inc. is laying off an unspecified number of workers in its Boulder research and development operation.
Source: dailycamera.com
Evolve and Pfizer cutting workers in Denver and Boulder
Denver-based Evolve is letting go of another 175 workers just four months after it dismissed 164 workers in response to a big drop-off in the vacation home rental market.
Source: denverpost.com